← Evidence map

ArticleLeukemia2012

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.

D J Morrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT01162551phase 25 enrolled2010
Full record →Abstract, authors, funding and every citing paper · PMID 21844871